![]() |
|
|
Vol. 26, Issue 3, 203-206, March 1998
Department of Pharmacy Practice and Science, College of Pharmacy, and the Center for Toxicology, The University of Arizona
| |
Abstract |
|---|
|
|
|---|
This study reports that cocaethylene undergoes an esterase-mediated ethyl ester exchange with ethanol, resulting in an increase in the apparent in vitro t1/2, compared with control conditions. Homogenized liver from male Sprague Dawley rats in pH 7.4 phosphate buffer was centrifuged at 9000g, and the resulting supernatant (S9) fraction was collected. Tubes containing the rat S9 fraction and 50 µM cocaethylene plus aqueous buffer (control), 50 mM ethanol, or 51.3 mM 2H6-ethanol were incubated at 37°C for 4 hr. Samples were collected from the incubation tubes at various times, extracted with a solid-phase extraction system, and assayed for cocaethylene and 2H5-cocaethylene by GC/MS. Concentration-time profiles were constructed and kinetic parameters were determined. The experiment was repeated in the presence of specific and nonspecific esterase inhibitors. Enzyme kinetic parameters were also determined. Cocaethylene underwent ethyl ester exchange, being converted to 2H5-cocaethylene in the presence of 2H6-ethanol. The average apparent in vitro t1/2 value for cocaethylene (13.0 ± 1.4 min) incubated with the S9 fraction and buffer only was increased ~5-fold (67.8 ± 0.3 min) in the presence of ethanol. Formation of 2H5-cocaethylene was totally blocked with the addition of bis-(p-nitrophenyl)phosphate but was unaffected by physostigmine. The intrinsic metabolite formation clearance of 2H5-cocaethylene from cocaethylene and 2H6-ethanol (1.92 ± 0.03 µl/min·mg protein) was several times greater than the corresponding value for cocaethylene formation from cocaine and ethanol (0.94 ± 0.01 µl/min·mg protein) or 2H6-ethanol (0.87 ± 0.04 µl/min·mg protein).
| |
Introduction |
|---|
|
|
|---|
The
coadministration of cocaine (benzoylmethylecgonine)
and ethanol produces a unique metabolite, cocaethylene
(benzoylethylecgonine, ethylcocaine), which possesses pharmacological
activity nearly identical to that of cocaine, a longer elimination
half-life, and greater toxicity than cocaine (Hearn et al.,
1991
; Woodward et al., 1991
; Katz et al., 1992
).
This metabolite is formed via a transesterification reaction
that is catalyzed by an hepatic carboxylesterase enzyme (Dean et
al., 1991
; Brzenzinski et al., 1994
; Boyer and
Petersen, 1992
). Recently, a microsomal carboxylesterase enzyme
responsible for cocaine hydrolysis has been implicated in this
transesterification reaction (Brzenzinski et al., 1994
; Boyer and Petersen, 1992
). We have hypothesized that cocaethylene, the
transesterification product formed from the interaction of cocaine and
ethanol, itself participates with ethanol in this interaction. The
transesterification of cocaethylene would involve the exchange of a
carboxyl ethyl group for the ethyl group of ethanol and, therefore, no
change in molecular structure. To monitor this exchange, deuterated
ethanol (2H6-ethanol) was
incubated with cocaethylene and the resultant deuterated product
(2H5-cocaethylene) was
assayed by GC/MS. To illustrate kinetic changes brought about by the
regeneration of parent compound via transesterification, drug was incubated with liver homogenates with and without unlabeled ethanol. A comparison of the ethanolic transesterification of cocaine
and cocaethylene was made by determining
KM, Vmax, and intrinsic metabolite formation clearance values for both substrates. Further characterization of the enzymatic interaction between cocaethylene and
2H6-ethanol was
accomplished by using specific and nonspecific esterase inhibitors.
| |
Materials and Methods |
|---|
|
|
|---|
Chemicals. Cocaine HCl and cocaethylene fumarate were provided by Research Triangle Institute (Chapel Hill, NC) through the generosity of the National Institute on Drug Abuse. Ethanol (absolute ethyl alcohol) was purchased from Quantum Chemical Corporation, USI Division (Tuscola, IL). 2H6-Ethanol (ethyl-d5-alcohol-d), physostigmine (eserine), BNPP,2 and 4-methylumbelliferyl acetate were purchased from Sigma Chemical Co. (St. Louis, MO).
Rat Liver S9 Fraction Preparation.
Male rats (250-275 g; Harlan Sprague Dawley, Indianapolis, IN) were
anesthetized with ether, and the entire liver was removed and washed in
cold KCl solution (1.15%). The livers were blotted dry, weighed, and
mixed with 70 mM KH2PO4
buffer solution at a ratio of 1 g liver/2 ml buffer solution. The
liver was homogenized by mixing for two 30-sec periods at high speed,
using an Omni-Mixer (Omni Corporation International, Waterbury, CT).
The homogenized liver was then centrifuged at 4°C for 30 min at
9000g (model J2-21; Beckman, Palo Alto, CA). Aliquots of
the resulting supernatant were placed in several polypropylene tubes
and stored frozen at
20°C. Esterase activity was determined by the
method of Dean et al. (1991)
, which uses
4-methylumbelliferyl acetate as the substrate. The esterase activity
was measured in freshly thawed liver (time 0) and at 1, 2, and 4 hr
after incubation at 37°C, to estimate any loss of activity resulting
from incubation. The formation of cocaethylene from cocaine and ethanol
in rat liver homogenate was measured as a positive control and to
assess carboxylesterase activity (data not shown). To rule out
nonenzymatic transesterification, cocaethylene was incubated with
ethanol, 2H6-ethanol, or
water in buffer solution. The total protein concentration was
determined with the use of a commercial product (bicinchoninic acid
protein assay; Pierce, Rockford, IL).
Drug Incubation. On the day of the incubation experiment, 1-ml aliquots of 100 µM solutions of cocaethylene in methanol were evaporated to dryness in a SpeedVac concentrator (Savant, Farmingdale, NY). The dry test tube contents were reconstituted with 0.9 ml of 70 mM KH2PO4 buffer solution, pH 7.4, and 0.1 ml of either deionized H2O (control), 5.86% (v/v) ethanol, or 5.86% (v/v) 2H6-ethanol. At the start of the incubation experiment, 1 ml of 9000g liver supernatant (S9 fraction) was added to each vial containing control, ethanol, or 2H6-ethanol solution (total volume, 2 ml), and the vials were capped and placed in a 37°C water bath. The final concentrations in each vial were 50 µM drug with buffer only (control), 50 mM ethanol, or 51.3 mM 2H6-ethanol. Ten samples of 100 µl each were taken from each tube, at the following times: 0, 5, 10, 15, 30, 45, 60, 120, 180, and 240 min. The 100-µl samples were immediately transferred to a vial (placed on ice) containing 100 µl of saturated NaF, to halt enzyme activity. The procedure described above was repeated in buffer solution for all three conditions, but only four samples each (0, 1, 2, and 4 hr) were collected. All experiments were conducted in triplicate and performed using a single homogenate preparation obtained from the livers of four rats.
To characterize the involvement of the carboxylesterase enzyme in the ethanolic transesterification of cocaethylene, the rat S9 fraction and 2H6-ethanol (51.3 mM) were incubated in the presence and absence of various specific and nonspecific esterase inhibitors. The rat S9 fraction in pH 7.4 buffer solution (0.8 ml) was combined with 0.1 ml of 2.87% (v/v) 2H6-ethanol and either 0.1 ml of H2O (positive control), 0.1 ml of saturated NaF (a nonspecific esterase inhibitor) in H2O, 0.1 ml of physostigmine (a specific cholinesterase inhibitor) (1 mM in H2O), or 0.1 ml of BNPP (a specific carboxylesterase inhibitor) (1 mM in H2O). Final inhibitor concentrations were 100 µM for physostigmine and BNPP and 10% saturated solution for NaF. In addition, a negative control solution was made containing 0.8 ml of pH 7.4 buffer, 0.1 ml of H2O, and 0.1 ml of 2.87% (v/v) 2H6-ethanol. Twenty glass tubes containing 100 µl each of 50 µM cocaethylene methanolic solution were evaporated to dryness. In quadruplicate, 100 µl each of the S9 fraction and buffer solution were added and incubated at 37°C. A single time 0 sample was collected for each of the five conditions, and at 30 min (the time at which maximum 2H5-cocaethylene concentrations occurred under control conditions) triplicate samples for each condition were collected. The reactions were stopped by the addition of 100 µl of saturated NaF and placement of the tube on ice.Enzyme Kinetics. The KM and Vmax values for the ethanolic transesterification of cocaine and cocaethylene were obtained from triplicate assays with the rat S9 fraction incubated with eight different concentrations of substrate for 10 min at 37°C. Reactions were stopped by placing the reaction tube on ice and adding 100 µl of saturated NaF solution. The concentrations of ethanol and 2H6-ethanol were kept constant at 50 mM (a physiologically relevant concentration equal to 0.230 g/100 ml ethanol), and the cocaine and cocaethylene concentrations ranged from 10 to 2500 µM. Three separate KM and Vmax determinations, each in triplicate, were made from the following combinations: cocaine plus ethanol, cocaine plus 2H6-ethanol, and cocaethylene plus 2H6-ethanol. Cocaethylene and 2H5-cocaethylene concentrations were assayed, and the rate of formation was determined by dividing by the incubation time and protein concentration. Substrate concentrations (micromolar) and corresponding rates (picomoles per minute·milligram) from individual experiments were analyzed by nonlinear regression (WinNonlin Scientific Consulting Inc., Apex, NC), fitting the data to the full nonlinear (hyperbolic) form of the Michaelis-Menten equation to obtain estimates of Vmax and KM.
Analytical Procedures. Samples from all experiments were extracted for cocaethylene and 2H5-cocaethylene with GV-50 Detectabuse solid-phase extraction columns (Biochemical Diagnostics Inc., Edgewood, NY). Columns were conditioned with 2 ml of methanol followed by 2 ml of 0.25 M K2HPO4 buffer, pH 9.1, with 7% n-propanol. To each sample was added 100 µl of internal standard solution (25 µM tropacocaine in H2O) and 3 ml of 0.25 M Na2HPO4 buffer, pH 9.1. The tubes were vortex-mixed and then decanted into the preconditioned solid-phase extraction columns. The columns were washed with 4 ml of 0.0625 M Na2HPO4 buffer solution and dried under vacuum at 10 in Hg for 10 min. Samples were eluted with 1 ml of methylene chloride/isopropyl alcohol (80:20) solution by gravity and collected in disposable glass test tubes (12 × 75 mm). The eluted extract was evaporated to dryness and then reconstituted with 50 µl of methanol just before GC/MS analysis.
Analysis of the extracted samples was accomplished using a model 5890 gas chromatograph equipped with a 5970 mass-selective detector (Hewlett Packard, Avondale, PA). The injection port of the gas chromatograph/mass-selective detector was set in the split mode (20:1), and 2 µl of reconstituted extracted samples were manually injected from a 10-µl Hamilton syringe. The gas chromatograph oven was operated isothermally at 240°C for a total run time of 4 min. The retention times were 1.6 min for tropacocaine and 2.8 min for both cocaethylene and 2H5-cocaethylene. Selected-ion monitoring was used to maximize sensitivity and specificity. Ion signals of m/z 82, 124, and 245 were used to identify the internal standard tropacocaine. Cocaethylene and 2H5-cocaethylene were identified by monitoring ions at m/z 82, 196, and 317 and m/z 82, 201, and 322, respectively. Quantitation of cocaethylene and 2H5-cocaethylene was accomplished by calculation of analyte/internal standard molecular weight ion signal ratios (m/z 317/245 and m/z 322/245, respectively) and comparison with a standard curve for cocaethylene extracted through the method (3.125, 6.25, 12.5, 25, and 50 µM). The limit of detection and limit of quantitation for the assay were 1.0 and 3.125 µM, respectively. Interday coefficients of variation for the assay were 8 and 4% for concentrations of 6.25 and 25 µM, respectively. For the KM and Vmax determinations and enzyme inhibitor experiments, analysis of the extracted samples used a 5890 gas chromatograph equipped with a model 5972 mass-selective detector and model 7673A autosampler (Hewlett Packard, Avondale, PA). The injection was split, and the isothermal oven temperature was set at 220°C. Only the quantitative molecular weight ions were monitored in the selected-ion monitoring mode, and the limits of detection and quantitation were 0.5 and 1.0 µM, respectively.Data Analysis.
Concentration-time profiles for cocaethylene and the deuterated
exchange product were constructed and kinetic parameters were obtained
using WinNonlin (Scientific Consulting). The apparent in
vitro t1/2 values were
calculated as 0.693/k, where k is the slope of
the log concentration vs. time plot. Statistical analysis of
the apparent t1/2,
KM, and Vmax
values was accomplished using Bonferroni's t test
(SigmaStat Statistical Software for Windows; Jandel Scientific
Software, San Rafael, CA). The harmonic mean and "pseudo"-standard
deviation of the apparent t1/2 values were calculated (Lam et al., 1985
).
| |
Results and Discussion |
|---|
|
|
|---|
The protein concentration of the rat S9 fraction was determined to be ~40 mg/ml. The mean esterase activity of freshly thawed rat S9 homogenate was 305 ± 4 nmol/min·mg of protein. Esterase activity did not significantly change after 1 and 2 hr of incubation (303 ± 14 nmol/min·mg and 293 ± 13 nmol/min·mg, respectively; using Bonferroni's t test for significance). After 4 hr of incubation, a statistically significant decrease in esterase activity was demonstrated (272 ± 5 nmol/min·mg; ~10% decrease from the control conditions). This reduced enzyme activity could affect the validity of the concentrations measured after 4 hr of incubation. No cocaethylene was detected after 4 hr of incubation under control conditions or after the addition of ethanol (fig. 1B). Deletion of the 4-hr value from the plot would not significantly alter the time profile for cocaethylene. Therefore, the significant loss of enzyme activity after 4 hr had little or no impact on the differences in cocaethylene t1/2 values with and without ethanol.
|
Incubation of cocaethylene in buffer only in the presence of 2H6-ethanol resulted in no 2H5-cocaethylene formation, ruling out nonenzymatic transesterification. There was, however, evidence of nonenzymatic hydrolysis of cocaethylene. From a starting concentration of 50 µM cocaethylene, there was a significant (p < 0.05) decrease in concentration after 4 hr of incubation (aqueous buffer, 41.5 ± 0.5 µM; ethanol, 41.6 ± 1.4 µM; 2H6-ethanol, 42.9 ± 0.3 µM).
The concentration-time profiles for unlabeled cocaethylene in the presence of 2H6-ethanol and for the formed 2H5-cocaethylene are illustrated in fig. 1A. These data clearly indicate that ethyl ester exchange occurs between unlabeled cocaethylene and 2H6-ethanol. The exchange process begins immediately upon incubation, inasmuch as measurable concentrations of 2H5-cocaethylene are seen within 5 min. Fig. 1A also illustrates total cocaethylene concentrations (i.e. obtained from the sum of labeled and unlabeled cocaethylene concentrations). That profile for total cocaethylene was virtually identical to the cocaethylene concentration-time profile measured in the presence of unlabeled ethanol (fig. 1B). Similarly, the unlabeled form of cocaethylene provided nearly identical concentration-time profiles under control conditions (i.e. no ethanol) (fig. 1B) and in the presence of 2H6-ethanol (fig. 1A). There were no statistically significant differences between those profiles in apparent t1/2 values (harmonic mean t1/2, 13.0 ± 1.4 min vs. 12.0 ± 1.1 min). This might appear to be inconsistent, because the disappearance of cocaethylene under control conditions is primarily the result of hydrolysis to benzoylecgonine and metabolism to other metabolites (i.e. ethylecgonine), whereas the disappearance of cocaethylene in the presence of 2H6-ethanol involves an additional pathway of formed 2H5-cocaethylene. However, the carboxylesterase enzyme is responsible for both the hydrolysis of cocaethylene to benzoylecgonine and the transesterification to 2H5-cocaethylene. Because the disappearance of parent compound (unlabeled cocaethylene) is approximately the same under the two conditions, presumably less initial benzoylecgonine would be formed in the presence of 2H6-ethanol, to compensate for the amount of parent compound being metabolized to 2H5-cocaethylene. Benzoylecgonine was not measured in this experiment and it might be difficult to illustrate this hypothesis, because the formed 2H5-cocaethylene would also be hydrolyzed to unlabeled benzoylecgonine. One might expect a similar area under the concentration-time curve (AUC) value for benzoylecgonine but a different profile, with less benzoylecgonine being formed early in the reactions involving ethanol and 2H6-ethanol vs. control. Fig. 1B illustrates the in vitro disposition of 50 µM cocaethylene with and without 50 mM unlabeled ethanol. The apparent t1/2 of cocaethylene was increased by ~5-fold in the presence of ethanol (13.0 ± 1.4 vs. 67.8 ± 0.3 min). The significant increase in the apparent t1/2 value in the presence of ethanol is explained by the ethyl ester formation of additional cocaethylene. This is corroborated by the extent of formation of 2H5-cocaethylene from 2H6-ethanol (fig. 1A). The change in the cocaethylene concentration-time profile in the presence of ethanol (fig. 1B) is identical to the change noted in a comparison of unlabeled cocaethylene and total cocaethylene in the presence of labeled ethanol (fig. 1A). The apparent t1/2 of unlabeled cocaethylene, 12.0 ±1.1 min, was increased to 72.3 ± 5.4 min for total cocaethylene (labeled and unlabeled) in the presence of 2H6-ethanol, a ~6-fold increase.
The experiments using enzyme inhibitors yielded an "all or nothing" response. Although the concentrations of cocaethylene and 2H5-cocaethylene were quantitatively determined, they are reported here qualitatively. When cocaethylene was incubated with the S9 fraction and 2H6-ethanol in the presence of BNPP, a specific carboxylesterase inhibitor, absolutely no formation of the product 2H5-cocaethylene was detected. Therefore, BNPP, a specific carboxylesterase inhibitor, totally blocked the ethyl ester exchange reaction between cocaethylene and 2H6-ethanol. As expected, no 2H5-cocaethylene was detected in the buffer condition (negative control) or when saturated NaF, a nonspecific esterase inhibitor, was added. However, when physostigmine, a cholinesterase inhibitor, was added to the S9 fraction, 2H6-ethanol, and cocaethylene incubation mixture, the formation product, 2H5-cocaethylene, was detected at approximately the same concentration as under positive control conditions (the S9 fraction with no inhibitors). Therefore, this ethyl ester exchange is most likely catalyzed by a carboxylesterase enzyme, namely the same transesterification enzyme system responsible for the formation of cocaethylene from cocaine and ethanol.
For the enzyme kinetic analysis, the rate of ethyl ester formation was
measured at different substrate concentrations and the data were fit to
the Michaelis-Menten equation. The apparent KM for cocaethylene formation from cocaine
and ethanol in the rat S9 fraction was 327 ± 6 µM (fig.
2A). The
KM value for this reaction has been
reported by others to be 116 µM (Woodward et al., 1991
)
and 864 µM (Katz et al., 1992
) in humans and mice, respectively. When
2H6-ethanol was substituted
for ethanol,
2H5-cocaethylene formation
from the cocaine substrate yielded a KM
value of 366 ± 25 µM (fig. 2B). Bonferroni's
t test determined that these two values were not
significantly different from each other, ruling out a kinetic isotope
effect with the deuterated ethanol. Vmax
values for cocaethylene and
2H5-cocaethylene formation
from the cocaine substrate were 305 ± 6 and 319 ± 9 pmol/min·mg, respectively (fig. 2, A and B).
The apparent KM and
Vmax values for
2H5-cocaethylene formation
from cocaethylene and
2H6-ethanol were 223 ± 4 µM and 428 ± 12 pmol/min·mg, respectively (fig.
2C). These values were significantly different from the cocaine substrate KM and
Vmax values (p < 0.05). From these data it appears that the rat carboxylesterase enzyme
more efficiently catalyzes the ethanolic transesterification of
cocaethylene, compared with that of cocaine. The lower
KM value (223 vs. 366 µM)
indicates that the enzyme has a greater affinity for cocaethylene than
for cocaine for ethanolic transesterification. The higher
Vmax (428 vs. 319 pmol/min·mg)
indicates more rapid transesterification of cocaethylene, compared with
cocaine, under similar substrate concentration conditions. This
conclusion is further supported by estimates of intrinsic metabolite
formation clearance
(Vmax/KM) values for cocaethylene formation. The values for cocaethylene formation clearance from cocaine and ethanol or
2H6-ethanol are 0.94 ± 0.01 and 0.87 ± 0.04 µl/min·mg protein, respectively. In
contrast, the intrinsic formation clearance estimate for
2H5-cocaethylene from
cocaethylene and
2H6-ethanol is 1.92 ± 0.03 µl/min·mg protein, a value several times the formation
clearance from cocaine.
|
The most important and novel aspect of this communication is the observation that cocaethylene undergoes ethyl ester exchange in the presence of ethanol. The prolonged half-life and reduced clearance of cocaethylene in the presence of ethanol are not indications of altered hepatic clearance because of ethanol interaction with metabolizing enzymes. That conclusion is supported by the observation that cocaethylene under control conditions (i.e. no ethanol) (fig. 2B) and unlabeled cocaethylene in the presence of 2H6-ethanol (fig. 2A) both underwent rapid and nearly identical elimination. Rather, a reversible metabolic system is established, with an excess of ethanol providing a substrate pool of an exchangeable ethyl group. This process would be expressed in a clinical setting as prolonged cocaethylene elimination in the presence of ethanol after cocaethylene has been formed by transesterification. Continued ethanol ingestion should further prolong the pharmacological and toxicological effects of the formed cocaethylene. We are currently examining this interaction using an in vivo animal model and a human liver preparation.
| |
Footnotes |
|---|
Received February 26, 1997; accepted September 11, 1997.
1 Current address: Associated Pathology Laboratory, 4230 S. Burnham, Las Vegas, NV 89119.
The authors gratefully acknowledge support for this work from a grant from the National Institute on Drug Abuse (DA08094).
Send reprint requests to: Michael Mayersohn, Ph.D., College of Pharmacy, The University of Arizona, Tucson, AZ 85721.
| |
Abbreviations |
|---|
Abbreviation used is: BNPP, bis-(p-nitrophenyl)phosphate.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. C. Laizure and R. B. Parker Pharmacodynamic Evaluation of the Cardiovascular Effects after the Coadministration of Cocaine and Ethanol Drug Metab. Dispos., February 1, 2009; 37(2): 310 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Laizure, T. Mandrell, N. M. Gades, and R. B. Parker Cocaethylene Metabolism and Interaction with Cocaine and Ethanol: Role of Carboxylesterases Drug Metab. Dispos., January 1, 2003; 31(1): 16 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Markowitz, C. L. DeVane, D. W. Boulton, Z. Nahas, S. C. Risch, F. Diamond, and K. S. Patrick Ethylphenidate Formation in Human Subjects after the Administration of a Single Dose of Methylphenidate and Ethanol Drug Metab. Dispos., June 1, 2000; 28(6): 620 - 624. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||